Trevi Therapeutics, Inc. (TRVI)

Trevi Therapeutics Statistics

Total Valuation

TRVI has a market cap or net worth of $1.50 billion. The enterprise value is $1.26 billion.

Market Cap	1.50B
Enterprise Value	1.26B

Important Dates

The last earnings date was Thursday, November 13, 2025, after market close.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

TRVI has 128.23 million shares outstanding. The number of shares has increased by 24.44% in one year.

Current Share Class	128.23M
Shares Outstanding	128.23M
Shares Change (YoY)	+24.44%
Shares Change (QoQ)	+11.32%
Owned by Insiders (%)	0.77%
Owned by Institutions (%)	76.69%
Float	95.24M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	7.67
P/TBV Ratio	7.68
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 21.93, with a Debt / Equity ratio of 0.00.

Current Ratio	21.93
Quick Ratio	21.69
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-51,351.00

Financial Efficiency

Return on equity (ROE) is -36.87% and return on invested capital (ROIC) is -25.60%.

Return on Equity (ROE)	-36.87%
Return on Assets (ROA)	-23.93%
Return on Invested Capital (ROIC)	-25.60%
Return on Capital Employed (ROCE)	-26.98%
Revenue Per Employee	n/a
Profits Per Employee	-$1.76M
Employee Count	26
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-32,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +290.38% in the last 52 weeks. The beta is 0.84, so TRVI's price volatility has been lower than the market average.

Beta (5Y)	0.84
52-Week Price Change	+290.38%
50-Day Moving Average	10.27
200-Day Moving Average	7.38
Relative Strength Index (RSI)	56.34
Average Volume (20 Days)	1,606,116

Short Selling Information

The latest short interest is 15.62 million, so 12.18% of the outstanding shares have been sold short.

Short Interest	15.62M
Short Previous Month	14.59M
Short % of Shares Out	12.18%
Short % of Float	16.41%
Short Ratio (days to cover)	9.51

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-51.35M
Pretax Income	-45.89M
Net Income	-45.86M
EBITDA	-51.20M
EBIT	-51.35M
Earnings Per Share (EPS)	-$0.37

Balance Sheet

The company has $194.93 million in cash and $823,000 in debt, giving a net cash position of $194.10 million or $1.51 per share.

Cash & Cash Equivalents	194.93M
Total Debt	823,000
Net Cash	194.10M
Net Cash Per Share	$1.51
Equity (Book Value)	189.79M
Book Value Per Share	1.48
Working Capital	189.26M

Cash Flow

In the last 12 months, operating cash flow was -$44.01 million and capital expenditures -$19,000, giving a free cash flow of -$44.03 million.

Operating Cash Flow	-44.01M
Capital Expenditures	-19,000
Free Cash Flow	-44.03M
FCF Per Share	-$0.34

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TRVI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-24.44%
Shareholder Yield	-24.44%
Earnings Yield	-3.15%
FCF Yield	-3.02%

Analyst Forecast

The average price target for TRVI is $20.59, which is 75.76% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$20.59
Price Target Difference	75.76%
Analyst Consensus	Strong Buy
Analyst Count	11
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-13.08%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2